Martin Shkreli, the disgraced former pharmaceutical executive, is accused of repeatedly violating his 2022 lifetime ban from the industry by trading pharma stocks and discussing the sector during social media livestreams. The FTC and seven state attorneys general are asking a federal judge to hold him in contempt.
Background
Martin Shkreli gained infamy for raising the price of the anti-parasitic drug Daraprim by over 4,000% and was sentenced to seven years in prison for fraud before receiving a lifetime industry ban in 2022.
- Source
- Ars Technica
- Published
- Oct 14, 2026 at 06:48 AM
- Score
- 7.0 / 10